Melola Discovery

← Melola Discovery

Akses terbuka Jurnal SINTA 1

The Activity of Liposome-Parijoto Formula Through p53 Expression in HepG2 Cell Line

Journal of Biomedicine and Translational Research · Vol. 9 No. 2 (2023) · hlm. 68–71

DOI
10.14710/jbtr.v9i2.17290
ISSN
2503-2178
Terbit
2023-08-31
Penerbit
Faculty of Medicine, Universitas Diponegoro
Bahasa
eng
Lisensi
creativecommons.org/licenses/by-sa/4.0

Abstrak

Parijoto, one of Melastomaceae family, has been known to have cytotoxic activity in HepG2, a hepatocellular cancer cell line, but with low activity. However, the ethyl acetate fraction of Parijoto gave the highest antioxidant and cytotoxic activity in 4T1. Then, purification and liposome formulation need to be carried out to increase the activity of Parijoto extract. Objective: This research aimed to study the cytotoxic activity and molecular mechanism of LEA (Liposom-Ethyl Acetate of Parijoto Fraction) in HepG2. Method: Extraction has been done by maceration, followed by partition using n-hexane, ethyl acetate, and methanol. LEA formulation was carried out by thin-layer hydration with modification and the formula was sized using a bath sonicator. Cytotoxic activity test of LEA and extract was performed in five serial concentrations (3,9 µg/mL–250 µg/mL), while the positive control doxorubicin performed in 3,9 µg/mL – 250 µg/mL by MTT assay. P53 gene expression was analyzed by using PCR-electrophoresis. Result: Results showed that LEA increased the cytotoxic activity (IC50 = 28.40 μg/ml). Furthermore, based on the electrophoresis study, LEA induced the p53 expression while the extract only did not. Conclusion: Liposome formula from ethyl acetate fraction of Parijoto extract (LEA) was able to increase cytotoxic activity and p53 gene expression was possible through the apoptotic mechanism. This shows that this formula is a promising strategy to improve the bioavailability of herbal medicines as cytotoxic agents.

Kata kunci

Jaringan kolaborasi para penulis

16 penulis · 40 tautan kepenulisan bersama · 10 lintas organisasi

Arahkan kursor atau ketuk sebuah nama untuk menyorot rekan penulisnya. Klik dua kali untuk membuka halaman penulis.

  • Diponegoro University
  • Sumatera Institute of Technology
  • Atma Jaya Catholic University of Indonesia
  • Bandung Institute of Technology
  • Afiliasi tidak diketahui
  • Organisasi berbeda
  • Organisasi sama
  • Afiliasi tidak diketahui
  • Garis lebih tebal = lebih banyak artikel bersama · lingkaran lebih besar = lebih banyak artikel
Tampilkan sebagai tabel
Rekan penulisOrganisasiArtikel bersama
Nuraini EkawatiDiponegoro University2
Intan Rahmania Eka DiniDiponegoro University2
M Alvien GhifariSumatera Institute of Technology1
Enny FachriyahDiponegoro University1
Dian NopitasariDiponegoro University1
Kautsar ElviraDiponegoro University1
Rama Esa PerdanaDiponegoro University1
Suci Zulaikha HildayaniBandung Institute of Technology1
Vivitri Dewi PrasastyAtma Jaya Catholic University of Indonesia1
Parsaoran SiahaanAfiliasi tidak diketahui1
Bungaran SimanjuntakDiponegoro University1

Afiliasi berasal dari OpenAlex; metadata OAI-PMH jurnal tidak memuatnya. Penulis tanpa ID OpenAlex dicocokkan berdasarkan nama, sehingga dua orang bisa tergabung atau satu orang bisa terpisah.

Sumber metadata: OAI-PMH (metadata jurnal) https://ejournal2.undip.ac.id/index.php/jbtr/oai, pertama di-harvest 9 Nov 2026, terakhir terlihat 9 Nov 2026.
Metadata asli (oai_dc)
<oai_dc:dc xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/  http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
	<dc:title xml:lang="en-US">The Activity of Liposome-Parijoto Formula Through p53 Expression in HepG2 Cell Line</dc:title>
	<dc:creator>sasikirana, widyandani</dc:creator>
	<dc:creator>Dianingati, Ragil Setia</dc:creator>
	<dc:creator>Anam, Khairul</dc:creator>
	<dc:creator>annisaa', eva</dc:creator>
	<dc:creator>Rohana, evieta</dc:creator>
	<dc:subject xml:lang="en-US">cytotoxic; formulation; bioavailability; Parijoto extract</dc:subject>
	<dc:description xml:lang="en-US">Parijoto, one of Melastomaceae family, has been known to have cytotoxic activity in HepG2, a hepatocellular cancer cell line, but with low activity. However, the ethyl acetate fraction of Parijoto gave the highest antioxidant and cytotoxic activity in 4T1. Then, purification and liposome formulation need to be carried out to increase the activity of Parijoto extract.  Objective: This research aimed to study the cytotoxic activity and molecular mechanism of LEA (Liposom-Ethyl Acetate of Parijoto Fraction) in HepG2. Method: Extraction has been done by maceration, followed by partition using n-hexane, ethyl acetate, and methanol. LEA formulation was carried out by thin-layer hydration with modification and the formula was sized using a bath sonicator.  Cytotoxic activity test of LEA and extract was performed in five serial concentrations (3,9 µg/mL–250 µg/mL), while the positive control doxorubicin performed in 3,9 µg/mL – 250 µg/mL by MTT assay. P53 gene expression was analyzed by using PCR-electrophoresis. Result: Results showed that LEA increased the cytotoxic activity (IC50 = 28.40 μg/ml). Furthermore, based on the electrophoresis study, LEA induced the p53 expression while the extract only did not. Conclusion: Liposome formula from ethyl acetate fraction of Parijoto extract (LEA) was able to increase cytotoxic activity and p53 gene expression was possible through the apoptotic mechanism. This shows that this formula is a promising strategy to improve the bioavailability of herbal medicines as cytotoxic agents.</dc:description>
	<dc:publisher xml:lang="en-US">Faculty of Medicine, Universitas Diponegoro</dc:publisher>
	<dc:date>2023-08-31</dc:date>
	<dc:type>info:eu-repo/semantics/article</dc:type>
	<dc:type>info:eu-repo/semantics/publishedVersion</dc:type>
	<dc:type xml:lang="en-US"></dc:type>
	<dc:format>application/pdf</dc:format>
	<dc:identifier>https://ejournal2.undip.ac.id/index.php/jbtr/article/view/17290</dc:identifier>
	<dc:identifier>10.14710/jbtr.v9i2.17290</dc:identifier>
	<dc:source xml:lang="en-US">Journal of Biomedicine and Translational Research; Vol 9, No 2 (2023): August 2023; 68-71</dc:source>
	<dc:source>2503-2178</dc:source>
	<dc:source>10.14710/jbtr.v9i2</dc:source>
	<dc:language>eng</dc:language>
	<dc:relation>https://ejournal2.undip.ac.id/index.php/jbtr/article/view/17290/9647</dc:relation>
	<dc:relation>https://ejournal2.undip.ac.id/index.php/jbtr/article/downloadSuppFile/17290/4325</dc:relation>
	<dc:rights xml:lang="en-US">Copyright (c) 2023 Journal of Biomedicine and Translational Research</dc:rights>
	<dc:rights xml:lang="en-US">https://creativecommons.org/licenses/by-sa/4.0</dc:rights>
</oai_dc:dc>